Stay updated with breaking news from Nasdaq Cdtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Rating) was the target of a large decline in short interest during the month of May. As of May 31st, there was short interest totalling 1,910,000 shares, a decline of 14.0% from the May 15th total of 2,220,000 shares. Based on an average daily volume of 2,590,000 shares, the […]
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Rating) was the target of a significant decline in short interest in the month of May. As of May 31st, there was short interest totalling 1,910,000 shares, a decline of 14.0% from the May 15th total of 2,220,000 shares. Based on an average daily trading volume, of 2,590,000 shares, […]
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Rating) was the target of a significant decrease in short interest during the month of May. As of May 15th, there was short interest totalling 2,220,000 shares, a decrease of 7.9% from the April 30th total of 2,410,000 shares. Based on an average trading volume of 3,070,000 shares, the […]
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Rating) saw a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 3,080,000 shares, a decrease of 13.2% from the March 31st total of 3,550,000 shares. Based on an average trading volume of 3,590,000 shares, the short-interest ratio is […]
StockNews.com upgraded shares of Cidara Therapeutics (NASDAQ:CDTX – Get Rating) from a hold rating to a buy rating in a research note released on Friday morning. Several other analysts also recently issued reports on CDTX. Cantor Fitzgerald reissued an overweight rating and issued a $5.00 price target on shares of Cidara Therapeutics in a report […]